|
DMRA Damora Therapeutics Inc 1800315 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-27,783,000.00 |
| Balance Sheet |
|
Current Assets
|
$535,408,000.00 |
|
Assets
|
$535,442,000.00 |
|
Current Liabilities
|
$23,812,000.00 |
|
Liabilities
|
$23,839,000.00 |
|
Equity
|
$511,603,000.00 |
|
Shares Out
|
60303212.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-20,598,000.00 |
|
Investing Cash Flow
|
$-17,374,000.00 |
| Market Analysis |
Market Cap
|
$1,761,456,822.52 |
|
Price
|
$29.41 |
|
BVPS
|
8.48 |
|
PB
|
3.44 |
|
EPS
|
-0.62 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:24 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:20 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DMRA documents filed with the SEC.
DMRA Filings
Clear
